Wachtel, Herbert http://orcid.org/0000-0002-6212-7061
Emerson-Stadler, Rachel
Langguth, Peter http://orcid.org/0000-0003-3758-7581
Hohlfeld, Jens M. http://orcid.org/0000-0003-2646-6186
Ohar, Jill http://orcid.org/0000-0002-2757-6806
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Received: 12 September 2023
Accepted: 21 November 2023
First Online: 9 January 2024
Declarations
:
: Herbert Wachtel and Rachel Emerson-Stadler are full-time employees of Boehringer Ingelheim. Peter Langguth has nothing to disclose. Jens M. Hohlfeld has received honoraria for board services, consultancy, and lectures outside the scope of this work from Boehringer Ingelheim Pharma & Co KG, CSL Behring GmbH, HAL Allergy Group, Merck & Co., Inc., Nocion Therapeutics, Novartis AG, and Roche. Jill Ohar reports consulting fees from AstraZeneca, Boehringer Ingelheim, Mylan, Sunovion, and Verona, and has received grants from Boehringer Ingelheim, Sunovion, Teva, and the Society to Improve Diagnosis in Medicine (SIDM) under a grant from the Gordon and Betty Moore Foundation.
: This analysis did not involve human participants or animals.